122 related articles for article (PubMed ID: 10950757)
1. Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection.
Koelle DM; Schomogyi M; Corey L
J Infect Dis; 2000 Sep; 182(3):662-70. PubMed ID: 10950757
[TBL] [Abstract][Full Text] [Related]
2. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
Milligan GN; Dudley-McClain KL; Young CG; Chu CF
J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes.
Braun RP; Payne LG; Dong L
Virol J; 2006 Jul; 3():54. PubMed ID: 16822314
[TBL] [Abstract][Full Text] [Related]
4. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
[TBL] [Abstract][Full Text] [Related]
5. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions.
Koelle DM; Abbo H; Peck A; Ziegweid K; Corey L
J Infect Dis; 1994 May; 169(5):956-61. PubMed ID: 8169426
[TBL] [Abstract][Full Text] [Related]
6. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
7. Impact of asymptomatic herpes simplex virus type 2 infection on mucosal homing and immune cell subsets in the blood and female genital tract.
Shannon B; Yi TJ; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Remis R; Rebbapragada A; Kaul R
J Immunol; 2014 Jun; 192(11):5074-82. PubMed ID: 24760150
[TBL] [Abstract][Full Text] [Related]
8. Persistence of herpes simplex virus type 2 VP16-specific CD4+ T cells.
Danke NA; Koelle DM; Kwok WW
Hum Immunol; 2005 Jul; 66(7):777-87. PubMed ID: 16112025
[TBL] [Abstract][Full Text] [Related]
9. HSV-2 induces TLRs and NF-kappaB-dependent cytokines in cervical epithelial cells.
Li H; Li X; Wei Y; Tan Y; Liu X; Wu X
Biochem Biophys Res Commun; 2009 Feb; 379(3):686-90. PubMed ID: 19124006
[TBL] [Abstract][Full Text] [Related]
10. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of human female primary genital epithelial cells to herpes simplex virus, type-2 and the effect of TLR3 ligand and sex hormones on infection.
MacDonald EM; Savoy A; Gillgrass A; Fernandez S; Smieja M; Rosenthal KL; Ashkar AA; Kaushic C
Biol Reprod; 2007 Dec; 77(6):1049-59. PubMed ID: 17881767
[TBL] [Abstract][Full Text] [Related]
12. [Herpes simplex virus and malignancies of female genital organs].
Cokić-Damjanović J; Horvat E; Balog A
Med Pregl; 2001; 54(9-10):432-7. PubMed ID: 11876004
[TBL] [Abstract][Full Text] [Related]
13. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus.
Tsunobuchi H; Nishimura H; Goshima F; Daikoku T; Suzuki H; Nakashima I; Nishiyama Y; Yoshikai Y
Virology; 2000 Sep; 275(1):57-66. PubMed ID: 11017787
[TBL] [Abstract][Full Text] [Related]
14. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
Posavad CM; Wald A; Hosken N; Huang ML; Koelle DM; Ashley RL; Corey L
J Immunol; 2003 Apr; 170(8):4380-8. PubMed ID: 12682275
[TBL] [Abstract][Full Text] [Related]
15. Immunity in latent Herpes simplex virus infection.
Bystrická M; Russ G
Acta Virol; 2005; 49(3):159-67. PubMed ID: 16178513
[TBL] [Abstract][Full Text] [Related]
16. The proliferative T cell response to herpes simplex virus (HSV) antigen is restricted by self HLA-D.
Berle EJ; Thorsby E
Clin Exp Immunol; 1980 Mar; 39(3):668-75. PubMed ID: 6247109
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity and immunosuppression in herpes simplex virus infection.
Rinaldo CR; Torpey DJ
Immunodeficiency; 1993; 5(1):33-90. PubMed ID: 8167747
[TBL] [Abstract][Full Text] [Related]
18. Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection.
Ashley R; Wald A; Corey L
J Virol; 1994 Aug; 68(8):5284-6. PubMed ID: 8035526
[TBL] [Abstract][Full Text] [Related]
19. Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection.
John M; Keller MJ; Fam EH; Cheshenko N; Hogarty K; Kasowitz A; Wallenstein S; Carlucci MJ; Tuyama AC; Lu W; Klotman ME; Lehrer RI; Herold BC
J Infect Dis; 2005 Nov; 192(10):1731-40. PubMed ID: 16235171
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.
Milligan GN; Dudley-McClain KL; Chu CF; Young CG
Virology; 2004 Jan; 318(2):507-15. PubMed ID: 14972519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
